Summary of Study ST004237

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002673. The data can be accessed directly via it's Project DOI: 10.21228/M84P1D This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST004237
Study TitleLipidomic analysis of the perigonadal adipose tissue of Control, HSL KO and ATGL KO mice.
Study SummaryAdipoCreERT2⁺ and AdipoCreERT2⁻ (control) mice carrying floxed alleles of Lipe (HSL) or Pnpla2 (ATGL) were treated with 4-hydroxy-tamoxifen to induce adipocyte-specific depletion of HSL or ATGL. Following gene deletion, white adipose tissue (WAT) samples were collected, and lipids were extracted. The hexane phases were isolated and analyzed by LC–MS/MS to quantify the complete triacylglycerol (TG) profile. While all TG species were measured, we specifically focused on short- and medium-chain fatty acid–containing TGs (SMCFA-TGs), where we detected marked differences in abundance between genotypes depending on the presence or absence of HSL or ATGL.
Institute
University of Szeged
Last NameDavid
First NameKovacs
AddressDóm tér 9, 6723
Emailkovacs.david@med.u-szeged.hu
Phone+3662342665
Submit Date2025-09-10
Raw Data AvailableYes
Raw Data File Type(s)mzML, raw(Thermo)
Analysis Type DetailLC-MS
Release Date2025-10-20
Release Version1
Kovacs David Kovacs David
https://dx.doi.org/10.21228/M84P1D
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR002673
Project DOI:doi: 10.21228/M84P1D
Project Title:Chain length-dependent mobilization and oxidation of fatty acids in adipocytes
Project Summary:Fatty acids (FAs) are essential metabolites in energy homeostasis. Adipocytes store FAs as triacylglycerol (TG) in their lipid droplets and mobilize them upon demand in order to provide energy for peripheral tissues. While the mobilization of long-chain fatty acids (LCFAs) during lipolysis is largely documented, there is little information on the metabolism of short- and medium-chain fatty acids (SMCFA) in adipocytes. We demonstrate that adipocytes store SMCFAs in their lipid droplets and that following lipolysis initiation, TGs containing SMCFAs undergo rapid hydrolysis. We found that this process is facilitated by the preferential accumulation of SMCFA-containing TGs at the surface of lipid droplets, thereby enhancing their accessibility to lipases. Unlike LCFAs, SMCFAs are not released from the adipocytes following lipolysis but undergo oxidation within the cell. Our findings suggest that SMCFAs are preferentially mobilized and oxidized to provide energy for the adipocyte, highlighting a distinct metabolic fate compared to LCFAs.
Institute:University of Szeged
Department:Institute of Biochemistry
Last Name:Kovacs
First Name:David
Address:Dóm tér 9, Szeged, Csongrád-Csanád, 6723, Hungary
Email:kovacs.david@med.u-szeged.hu
Phone:+3662342665

Subject:

Subject ID:SU004389
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090

Factors:

Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id Genotype Injection order Sample source
SA486480221130_C-806_Pos1ATGL KO 1 WAT
SA486481221130_C-807_Pos1ATGL KO 1 WAT
SA486482221130_C-841_Pos1ATGL KO 1 WAT
SA486483221130_C-843_Pos1ATGL KO 1 WAT
SA486484221130_C-807_Pos2ATGL KO 2 WAT
SA486485221130_C-841_Pos2ATGL KO 2 WAT
SA486486221130_C-843_Pos2ATGL KO 2 WAT
SA486487221130_C-806_Pos2ATGL KO 2 WAT
SA486488221130_C-841_Pos3ATGL KO 3 WAT
SA486489221130_C-807_Pos3ATGL KO 3 WAT
SA486490221130_C-843_Pos3ATGL KO 3 WAT
SA486491221130_C-806_Pos3ATGL KO 3 WAT
SA486492221130_C-841_Pos4ATGL KO 4 WAT
SA486493221130_C-807_Pos4ATGL KO 4 WAT
SA486494221130_C-843_Pos4ATGL KO 4 WAT
SA486495221130_C-806_Pos4ATGL KO 4 WAT
SA486496221130_A-808_Pos1Control 1 WAT
SA486497221130_A-824_Pos1Control 1 WAT
SA486498221130_A-826_Pos1Control 1 WAT
SA486499221130_A-834_Pos1Control 1 WAT
SA486500221130_A-824_Pos2Control 2 WAT
SA486501221130_A-808_Pos2Control 2 WAT
SA486502221130_A-826_Pos2Control 2 WAT
SA486503221130_A-834_Pos2Control 2 WAT
SA486504221130_A-808_Pos3Control 3 WAT
SA486505221130_A-824_Pos3Control 3 WAT
SA486506221130_A-826_Pos3Control 3 WAT
SA486507221130_A-834_Pos3Control 3 WAT
SA486508221130_A-834_Pos4Control 4 WAT
SA486509221130_A-808_Pos4Control 4 WAT
SA486510221130_A-824_Pos4Control 4 WAT
SA486511221130_A-826_Pos4Control 4 WAT
SA486512221130_B-781_Pos1HSL KO 1 WAT
SA486513221130_B-778_Pos1HSL KO 1 WAT
SA486514221130_B-780_Pos1HSL KO 1 WAT
SA486515221130_B-835_Pos1HSL KO 1 WAT
SA486516221130_B-778_Pos2HSL KO 2 WAT
SA486517221130_B-835_Pos2HSL KO 2 WAT
SA486518221130_B-781_Pos2HSL KO 2 WAT
SA486519221130_B-780_Pos2HSL KO 2 WAT
SA486520221130_B-835_Pos3HSL KO 3 WAT
SA486521221130_B-781_Pos3HSL KO 3 WAT
SA486522221130_B-780_Pos3HSL KO 3 WAT
SA486523221130_B-778_Pos3HSL KO 3 WAT
SA486524221130_B-778_Pos4HSL KO 4 WAT
SA486525221130_B-835_Pos4HSL KO 4 WAT
SA486526221130_B-781_Pos4HSL KO 4 WAT
SA486527221130_B-780_Pos4HSL KO 4 WAT
Showing results 1 to 48 of 48

Collection:

Collection ID:CO004382
Collection Summary:The mouse models used in this study were generated previously by insertion of LoxP sites in the Lipe gene encoding HSL, or in the Pnpla2 gene encoding ATGL. To obtain adipocyte specific knock-out, these mice were crossed with transgenic mice (Tg(Adipoq-cre/ERT2)1Soff/J) expressing the tamoxifen-inducible Cre-ERT2 recombinase, expressed under the control of the adiponectin promoter, specific for adipose tissue. 7-week old mice were gavaged with tamoxifen (1 mg/day for 5 days, SIGMA T5648-1G) to induce adipocyte-specific deletion of HSL (HSLAdipo-/-) or ATGL (ATGLAdipo-/- mice). Control littermate were Atgl+/+ Hslfl/fl AdipoQ-Cre/ERT2-, Atglfl/fl Hsl+/+ AdipoQ-Cre/ERT2- and Hslfl/fl Atglfl/fl AdipoQ-Cre/ERT2-. Mice were fed chow (Ssniff V1534). Mice were housed and manipulated according to Inserm guidelines and European Directive 2010/63/UE in the local animal care facility (agreements A 31 555 04 and C 31 555 07). Protocols were approved by the French Ministry of Research after review by local ethical committee (comité d’éthique en experimentation animale de l’UMS006/CREFRE, CEEA122, Toulouse, France). For lipidomic analysis, perigonadal white adipose tissued were collected, and 8-13 mg samples were extracted.
Sample Type:Adipose tissue

Treatment:

Treatment ID:TR004398
Treatment Summary:Mice with different genotypes were used

Sample Preparation:

Sampleprep ID:SP004395
Sampleprep Summary:To extract lipids from tissue samples, a 3-phase liquid extraction was performed to separate neutral and polar lipids. First, tissue samples were measured on an analytical scale then transferred into glass tubes, containing already the internal standard mix (Splash) and TG 6:0/6:0/6:0. Then, to reduce sample loss, 0.75 mL of ACN were added to microtubes, vortexed, and transferred into the corresponding glass tubes. The remaining solvents were added to each sample: 0.75 mL Hex, 0.25 mL EtAc. The aqueous phase (sample) was completed with ultrapure water when needed, resulting in Hex:EtAc:ACN:Aqueous (3:1:3:2, V:V:V:V). Tissue samples were first vortexed for 30 min at 4oC with glass beads, and only then centrifuged. The upper phase was collected into a new tube with a Hamilton glass syringe, which was washed three times in solvent between samples. Hex was added (half the volume of the first extraction) to the 2 remaining phases for re-extraction. Samples were again vortexed and centrifuged, and upper and middle phases were collected separately. To reduce phospholipid loss, a re-extraction of middle phase was done with ACN:EtAc (3:1, V:V) (half the volume of first extraction). Extraction (solvents and water) and experiment blanks (PBS) were included. All extraction solvents had 50 μg/mL BHT. Extracted samples were kept dried at -20oC under Ar.

Chromatography:

Chromatography ID:CH005356
Instrument Name:Thermo Dionex Ultimate 3000
Column Name:Thermo Accucore C18 (150 x 2.1mm,2.6um)
Column Temperature:35°C
Flow Gradient:0.0 min, 35% B; 4.0 min, 60% B; 8.0 min, 70% B; 16.0 min, 85% B; 25.0 min, 97% B.
Flow Rate:400 µl/min
Solvent A:50% Acetonitrile/50% Water; 10 mM ammonium formate; 0.1% formic acid
Solvent B:88% Isopropanol/10% Acetonitrile/2% Water; 2 mM ammonium formate; 0.02 % formic acid
Chromatography Type:Reversed phase

Analysis:

Analysis ID:AN007054
Laboratory Name:CNRS Institute of Molecular and Cellular Pharmacology
Analysis Type:MS
Chromatography ID:CH005356
Num Factors:12
Num Metabolites:184
Units:Peak Intensity
  logo